exVive3D
Organovo’s 3D Printed Liver Tissue Shows Extended Survival and Function in Animal Test Subjects
Organovo is a well-known company to anyone involved in 3D printing, tissue engineering or both. While many are familiar with the company’s 3D printed liver and kidney tissues, however, it’s…
More 3D Printing Executive Transitions as Organovo CEO Keith Murphy Steps Down, to be Replaced by Taylor J. Crouch
This year has been a tumultuous one in the 3D printing industry so far. January saw the resignation of MakerBot CEO Jonathan Jaglom, who was replaced by Nadav Goshen, and…
Organovo Presents Data on 3D Printed Kidney and Liver Tissue at Society of Toxicology Annual Meeting
We received our last update on 3D bioprinting company Organovo a couple of weeks ago, when it released a plethora of new information regarding the performance of its 3D printed kidney…
Recently Released Studies Show Increasing Promise of Organovo 3D Printed Kidney and Liver Tissue for Pharmaceutical Testing
If you’re only marginally familiar with bioprinting and have heard of just one company in the industry, it’s likely that company is Organovo. The San Diego company was one of the…
Organovo Partners with Murdoch Childrens Research Institute for Bioprinted Kidney Research
The name Organovo is one that instantly commands admiration, if not awe, from anyone familiar with it. The tissue engineering company is something of a hero within both the medical and…
Organovo Subsidiary Samsara Sciences Launches Commercial Operations, Will Be Dedicated Cell Provider for 3D Bioprinting Company
We’ve covered a lot of stories on bioprinting, as the technology continues to develop with exciting implications for medicine. It’s become a race of sorts, with several companies striving to…
Organovo (ONVO) Reports 209% Revenue Growth Thanks to 3D Printed exVive3D Liver Tissue
When it comes to 3D printing human tissue, Organovo (ONVO) is leading the charge. While the company’s stock has floundered as of late, dropping to as low as $2.78 last…
Organovo Reports Fiscal 2015 Financial Results — Sales of 3D Printed exVive3D Liver Tissue Heat Up
Organovo (NYSE MKT:ONVO) is one of those companies which seems to be almost too ahead of their time to really be taken seriously from an investment standpoint. That’s at least the…
Organovo & Merck Enter Multi-year Research Partnership for 3D Printed Human Tissue
The 3D bioprinting space may be about to take off in a big way. As investment dollars flow into companies seeking to transform medicine via the 3D printing of biological…
Organovo Presents Data on Fully Cellular 3D Bioprinted Kidney Tissue
Bioprinting is in our future. No longer the stuff of sci-fi dreams, the technology is taking a true hold in today’s world — and even in the dictionary. By bringing…
exVive3D 3D Printed Human Liver Tissue Now Commercially Available by Organovo
New technologies such as 3D bioprinting promise to offer a laundry list of new treatments, drug discovery, and cures within the medical industry. With that said, we have been hearing…
